89Bio Inc (ETNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Operating Expenses | 57,277 | 41,206 | 39,345 | 42,129 | 28,524 |
| Operating Income | -57,277 | -41,206 | -39,345 | -42,129 | -28,524 |
| Interest Expense | 863 | 866 | 959 | 894 | 2,075 |
| Other Income | 6,556 | 5,704 | 5,579 | 4,630 | 1,763 |
| Pre-tax Income | -51,584 | -36,368 | -34,725 | -38,393 | -28,836 |
| Income Tax | 97 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -51,681 | -40,235 | -34,725 | -38,393 | -28,836 |
| Net Income | $-51,681 | $-40,235 | $-34,725 | $-38,393 | $-28,836 |
| EPS Basic Total Ops | -0.54 | -0.49 | -0.45 | -0.52 | -0.54 |
| EPS Basic Continuous Ops | -0.54 | -0.48 | -0.45 | -0.52 | -0.54 |
| EPS Diluted Total Ops | -0.54 | -0.49 | -0.45 | -0.52 | -0.54 |
| EPS Diluted Continuous Ops | -0.54 | -0.48 | -0.45 | -0.52 | -0.54 |
| EPS Diluted Before Non-Recurring Items | -0.54 | -0.50 | -0.45 | N/A | N/A |
| EBITDA(a) | $-57,106 | $-42,956 | $-41,205 | $-44,070 | $-28,291 |